| |
Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
Determining the safety of a product, whether it is a pharmaceutical, biopharmaceutical, medical device or pesticide, may also include demonstrating its genotoxic potential.
|
Back to Toxicology
BioReliance offers complete genetic toxicology services
for the detection of toxic, mutagenic, clastogenic, and morphological
transforming activity in a number of well-characterized test systems.
Our scientific staff and state-of-the-art facilities provide the
most complete and comprehensive genetic toxicology resources available
anywhere.
We can tailor a comprehensive testing program
to fit each client's needs. Protocols are designed according to
international guidelines (FDA, EPA, OECD, EU, JMHW, and JMAFF) and
are conducted in full compliance with Good Laboratory Practice (GLP)
regulations. We apply the most sophisticated battery of tests available
for the detection of genotoxic potential.
At BioReliance, our genetic toxicology services can:
- Identify genotoxic agents to humans
- Support interpretation of other tox results
- Provide support for regulatory decisions
- Alert producers and users of potential hazard
- Help with drug discovery decisions
Our genetic toxicology services include:
- In Vitro Cytogenetics
- In Vivo Cytogenetics
- Assessment of Hemolytic Property
|
 |
|
|
